Besides the elucidation of the exact mechanisms that underlie the effect of Nrf2 on obesity and metabolism in general, it is important to consider which options are already available for clinical manipulation of the Keap1/Nrf2 pathway. This evidence concerns the gene KEAP1 and obesity due to melanocortin 4 receptor deficiency.